PROFOUNDBIO
ProfoundBio is a clinical-stage biotechnology company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer. Built on internally developed, innovative, and proprietary technology platforms, ProfoundBio has developed a pipeline consisting of multiple antibody-drug conjugate (ADC) drug candidates targeting solid tumors and hematological malignancies that are in discovery, preclinical, and clinical development stages.
PROFOUNDBIO
Social Links:
Industry:
Biotechnology Oncology Therapeutics
Founded:
2018-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.profoundbio.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
247 M USD
Technology used in webpage:
Domain Not Resolving Euro
Similar Organizations
Aro Biotherapeutics
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Novasenta
Novasenta develops treatments to transform the lives of patients with cancer.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
RefleXion Medical
RefleXion Medical is a developer of biologically-guided radiotherapy systems for patients with cancer.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Advisors List
Current Employees Featured
Founder
Investors List
Lilly Asia Ventures
Lilly Asia Ventures investment in Series B - ProfoundBio
Ally Bridge Group
Ally Bridge Group investment in Series B - ProfoundBio
T. Rowe Price
T. Rowe Price investment in Series B - ProfoundBio
Janus Henderson Investors
Janus Henderson Investors investment in Series B - ProfoundBio
LYFE Capital
LYFE Capital investment in Series B - ProfoundBio
Logos Capital
Logos Capital investment in Series B - ProfoundBio
Piper Heartland Healthcare Capital
Piper Heartland Healthcare Capital investment in Series B - ProfoundBio
LifeSci Venture Partners
LifeSci Venture Partners investment in Series B - ProfoundBio
Medicxi
Medicxi investment in Series B - ProfoundBio
Surveyor Capital
Surveyor Capital investment in Series B - ProfoundBio
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-08 | ProfoundBio to Highlight Programs and Technology at AACR 2022 Annual Meeting; Welcomes Zhu Chen, PhD, as Chief Scientific Officer |
Official Site Inspections
http://www.profoundbio.com Semrush global rank: 4.67 M Semrush visits lastest month: 2.02 K
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ProfoundBio"
ProfoundBio - Crunchbase Company Profile & Funding
ProfoundBio is a clinical-stage biotechnology company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer. Built on internally developed, innovative, and proprietary …See details»
ProfoundBio Company Profile 2024: Valuation, Investors
ProfoundBio General Information Description. Developer of novel targeted therapeutics …See details»
Genmab Completes Acquisition of ProfoundBio - Genmab A/S
May 21, 2024 The acquisition gives Genmab worldwide rights to ProfoundBio’s portfolio of …See details»
ProfoundBio - LinkedIn
ProfoundBio | 3,947 followers on LinkedIn. ProfoundBio is now part of Genmab. As part of Genmab, we are looking forward to continuing our work of developing novel antibody-based therapeutics for ...See details»
ProfoundBio - Funding, Financials, Valuation & Investors
ProfoundBio is a developer of targeted therapeutics intended for patients with cancer. Search …See details»
ProfoundBio (Suzhou) Co., Ltd. - synapse.zhihuiya.com
了解ProfoundBio (Suzhou) Co., Ltd. (普方生物制药（苏州）有限公司)公司的药物管线，治疗领 …See details»
ProfoundBio, led by Seagen veterans and co-located in China
Jul 14, 2021 ProfoundBio is developing new antibody-drug conjugates, a technology that is …See details»
ADC startup ProfoundBio, led by Seagen veterans, raises $112M
Feb 13, 2024 ProfoundBio’s raise comes at a time when funding for cancer drug startups has …See details»
Genmab to buy ProfoundBio, picking up targeted chemotherapies
Apr 3, 2024 L ONDON — The Danish firm Genmab said Wednesday it would acquire …See details»
ProfoundBio Announces Completion of More Than $55 million …
Jul 12, 2021 WOODINVILLE, Wash. and SUZHOU, China, July 12, 2021 /PRNewswire/ -- …See details»
ProfoundBio, led by Seagen veterans, raises $70M – GeekWire
Jun 2, 2022 ProfoundBio, led by Seagen veterans, raises $70M. by Charlotte Schubert on …See details»
ProfoundBio Raises $112 Million in Oversubscribed Series B Equity ...
Feb 13, 2024 ProfoundBio, a clinical-stage biotechnology company developing novel antibody …See details»
Genmab buys ProfoundBio for $1.8B, adding to ADC dealmaking …
Apr 3, 2024 ProfoundBio’s lead drug, Rina-S, is a would-be competitor for Elahere, which …See details»
ProfoundBio Announces Completion of $70 Million Series A
Jun 2, 2022 ProfoundBio has raised a total of more than $138 million in the past two years. …See details»
ProfoundBio - Contacts, Employees, Board Members, Advisors
ProfoundBio has 8 current employee profiles, including Chief Medical Officer Naomi Hunder. …See details»
ProfoundBio Raises $112 Million in Oversubscribed Series B Equity ...
Feb 13, 2024 ProfoundBio's Cutting-Edge Investigational ADC Programs. Rinatabart …See details»
PRO-1107 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 25, 2024 About ProfoundBio ProfoundBio is a clinical-stage biotechnology company …See details»
ProfoundBio - Updates, News, Events, Signals & Triggers
Organization. ProfoundBio . Connect to CRM . Save . Summary. Financials. People. …See details»
The morning after ProfoundBio | ApexOnco - Clinical Trials news …
Nov 8, 2024 Seven months after shelling out $1.8bn for the ADC specialist ProfoundBio, …See details»
ProfoundBio - Tech Stack, Apps, Patents & Trademarks - Crunchbase
ProfoundBio has 1 registered patent in the ' Organic Chemistry ' category, according to …See details»